Dade Behring was a company which manufactured testing machinery and supplies for the medical diagnostics industry, based in Deerfield, Illinois and Glasgow, Delaware (formerly a DuPont site).
Behring Diagnostics, a Frankfurt-based [1] company bearing Dr. Emil von Behring's name, was spun off from Hoechst AG (which later became Aventis) in 1995. Soon after its formation, the company acquired a drug-testing firm called Syva Company and, in 1996, the diagnostics and clinical chemistry division of DuPont. [2]
Dade Behring was born from the merger of Behring Diagnostics and Deerfield, Illinois-based [1] Dade International, a private, independent company created by a group of investors led by Bain Capital [3] who had bought Baxter International's diagnostics unit for over $440 million, in late 1994. The combined operations of the two companies reached sales of $1.2 billion and employed a workforce of 6,400 worldwide.
The new firm became the world's largest company devoted to diagnostics, with sales of over $500 million. The "Dade" part of the name is a legacy of the Dade Reagents Company, founded by Dr. John Elliott near the end of the 1940s to provide consistent, high quality typing and testing of blood.
Jim Reid-Anderson joined Dade Behring Holdings Inc, in 1996 as executive vice president and chief financial officer (CFO) and became chief administrative officer and CFO in September 1997.
Nelson Chai joined Dade Behring in 1997 as corporate vice president of worldwide field finance; he later became their senior vice president of business development. [4]
In April 1999, Reid-Anderson was promoted to the role of president and chief operating officer and then CEO in September 2000. He was elected as the chairman of the board in October 2002.
In 2002 the company filed for Chapter 11 bankruptcy, but then reorganized and recovered in a spectacular way. Brad Pattelli was on the board of directors and an influential figure in the reorganization. By 2005, the firm employed more than 6,000 workers and had operations in 43 countries to serve more than 25,000 medical customers.
With 2006 revenue of more than $1.7 billion, Dade Behring was the world's largest company solely dedicated to clinical diagnostics, as opposed to competitors like Abbott and Roche, whose operations covered other markets including the pharmaceutical industry.
In 2007 Dade Behring was acquired by the German conglomerate Siemens AG. [5] Based on Dade's 83 million outstanding shares, Siemens’ offer of $77 a share in cash, on a diluted basis, had a value of nearly $6.4 billion.
Siemens AG is a German multinational technology conglomerate. It is focused on industrial automation, distributed energy resources, rail transport and health technology. Siemens is the largest industrial manufacturing company in Europe, and holds the position of global market leader in industrial automation and industrial software.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Chiron Corporation was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.
Bain Capital, LP is an American private investment firm based in Boston, Massachusetts, with around $185 billion of assets under management. It specializes in private equity, venture capital, credit, public equity, impact investing, life sciences, crypto, tech opportunities, partnership opportunities, special situations, and real estate. Bain Capital invests across a range of industry sectors and geographic regions. The firm was founded in 1984 by partners from the consulting firm Bain & Company. The company is headquartered at 200 Clarendon Street in Boston with 22 offices in North America, Europe, Asia, and Australia.
John Alexander Thain is an American financial executive and investment banker. He was president and co-COO of Goldman Sachs, and then CEO of the New York Stock Exchange. Thain then became the last chairman and CEO of Merrill Lynch & Co. before its merger with Bank of America. He was designated to become president of global banking, securities, and wealth management at the newly combined company, but resigned on January 22, 2009. Ken Lewis, CEO of Bank of America, reportedly forced Thain to step down after several controversies, such as the losses at Merrill Lynch which proved to be far larger than previously estimated, and the award of huge executive bonuses. Thain then was chairman and CEO of the CIT Group. He has been a board member of Uber since 2017.
Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi.
St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.
Siemens Healthineers is a German company which provides healthcare services. It was spun off from its parent company Siemens in 2017, which retains a 75% stake. Siemens Healthineers is the parent company for several medical technology companies and is headquartered in Erlangen, Germany.
Ortho Clinical Diagnostics is an in vitro diagnostics company that made products and diagnostic equipment for blood testing. Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion recipients receive appropriate and compatible blood.
A medical laboratory or clinical laboratory is a laboratory where tests are conducted out on clinical specimens to obtain information about the health of a patient to aid in diagnosis, treatment, and prevention of disease. Clinical medical laboratories are an example of applied science, as opposed to research laboratories that focus on basic science, such as found in some academic institutions.
Nelson Joosuk Chai is an American investment banker and financial executive. He formerly served as the chief financial officer of American financial services company Merrill Lynch and briefly as Bank of America's president for the Asia-Pacific region. He is the former president of CIT Group and reported directly to then CEO John Thain. On August 21, 2018, it was announced that Chai has been hired as the chief financial officer of Uber.
Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.
James Reid-Anderson is a British businessman who was formerly the president, chairman, and chief executive officer (CEO) of Six Flags Entertainment Corporation. Before working for Six Flags, Anderson was previously a healthcare adviser to both Apollo and the managing board of Siemens AG. Under Reid-Anderson, Dade Behring was acquired by Siemens.
Merrill, previously branded Merrill Lynch, is an American investment management and wealth management division of Bank of America. Along with BofA Securities, the investment banking arm, both firms engage in prime brokerage and broker-dealer activities. The firm is headquartered in New York City, and once occupied the entire 34 stories of 250 Vesey Street, part of the Brookfield Place complex in Manhattan. Merrill employs over 14,000 financial advisors and manages $2.8 trillion in client assets. The company also operates Merrill Edge, a division for investment and related services, including call center counsultancy.
Behring may refer to:
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2021, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano (Italy), Dietzenbach (Germany), Stillwater, Minnesota (US), Dartford (UK). Following the acquisition of Luminex, the company acquired five additional production plants located in the United States and in Canada (Toronto). The company is a constituent of the FTSE MIB index.
Laurence A. Tosi is an American entrepreneur, investor, and philanthropist. Tosi is currently a Managing Partner of WestCap Group, the investment firm he founded. In October 2020, it was reported that Tosi's firm was in the final stages of raising a $750 million fund and had received about $1.2 billion of investor interest to date. Prior to dedicating his time to WestCap, Tosi served as the chief financial officer of Airbnb and of The Blackstone Group and held several roles at BofA Merrill Lynch.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
Thomas C. Naratil is an American business executive in the financial industry. After serving as president of both UBS Wealth Management Americas and UBS Americas since early 2016, Naratil was appointed CEO of UBS Americas Holding LLC and became co-president of Global Wealth Management of UBS Group AG and UBS AG in early 2018.
Joseph Willett is an American investment banker who served as the chief financial officer (CFO) of investment bank Merrill Lynch & Co. from 1993 to 1998. He would go on to serve as the chief operating officer (COO) Merrill Lynch's European operations from 1998 to 2002, succeeded by Andrea Orcel.
| International | |
|---|---|
| Other | |
